373 related articles for article (PubMed ID: 25812756)
1. Therapeutic angiogenesis for critical limb ischemia.
Ko SH; Bandyk DF
Semin Vasc Surg; 2014 Mar; 27(1):23-31. PubMed ID: 25812756
[TBL] [Abstract][Full Text] [Related]
2. Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.
Lakshmanan R; Ukani G; Rishi MT; Maulik N
Can J Physiol Pharmacol; 2017 Oct; 95(10):1125-1140. PubMed ID: 28407473
[TBL] [Abstract][Full Text] [Related]
3. Review of the Current Basic Science Strategies to Treat Critical Limb Ischemia.
Haghighat L; Ionescu CN; Regan CJ; Altin SE; Attaran RR; Mena-Hurtado CI
Vasc Endovascular Surg; 2019 May; 53(4):316-324. PubMed ID: 30808262
[TBL] [Abstract][Full Text] [Related]
4. Clinical effectiveness of gene therapy on critical limb ischemia: a meta-analysis of 5 randomized controlled clinical trials.
Miao YL; Wu W; Li BW; Fang WW; Liu Y; Li L; Mi WD
Vasc Endovascular Surg; 2014; 48(5-6):372-7. PubMed ID: 24951292
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis for peripheral artery disease: gene therapy.
Nikol S
Vasa; 2007 Aug; 36(3):165-73. PubMed ID: 18019272
[TBL] [Abstract][Full Text] [Related]
6. NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia.
Maulik N
Curr Opin Investig Drugs; 2009 Mar; 10(3):259-68. PubMed ID: 19333884
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis in critical limb ischemia.
Ouma GO; Zafrir B; Mohler ER; Flugelman MY
Angiology; 2013 Aug; 64(6):466-80. PubMed ID: 23129733
[TBL] [Abstract][Full Text] [Related]
8. Insights into gene therapy for critical limb ischemia: the devil is in the details.
Madonna R; Rokosh G
Vascul Pharmacol; 2012 Aug; 57(1):10-4. PubMed ID: 22580542
[TBL] [Abstract][Full Text] [Related]
9. Gene-based therapies in patients with critical limb ischemia.
Kitrou P; Karnabatidis D; Brountzos E; Katsanos K; Reppas L; Spiliopoulos S
Expert Opin Biol Ther; 2017 Apr; 17(4):449-456. PubMed ID: 28133976
[TBL] [Abstract][Full Text] [Related]
10. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic angiogenesis. Devising new strategies based on past experiences.
Lei Y; Haider HKh; Shujia J; Sim ES
Basic Res Cardiol; 2004 Mar; 99(2):121-32. PubMed ID: 14963670
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review.
Attanasio S; Snell J
Cardiol Rev; 2009; 17(3):115-20. PubMed ID: 19384084
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic angiogenesis for critical limb ischaemia.
Annex BH
Nat Rev Cardiol; 2013 Jul; 10(7):387-96. PubMed ID: 23670612
[TBL] [Abstract][Full Text] [Related]
14. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
[TBL] [Abstract][Full Text] [Related]
15. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.
Lawall H; Bramlage P; Amann B
Thromb Haemost; 2010 Apr; 103(4):696-709. PubMed ID: 20174766
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic angiogenesis: controlled delivery of angiogenic factors.
Chu H; Wang Y
Ther Deliv; 2012 Jun; 3(6):693-714. PubMed ID: 22838066
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Benefits and Adverse Effects of Combined Proangiogenic Gene Therapy in Mouse Critical Leg Ischemia.
Lebas B; Galley J; Renaud-Gabardos E; Pujol F; Lenfant F; Garmy-Susini B; Chaufour X; Prats AC
Ann Vasc Surg; 2017 Apr; 40():252-261. PubMed ID: 27903483
[TBL] [Abstract][Full Text] [Related]
18. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia.
Beltrán-Camacho L; Rojas-Torres M; Durán-Ruiz MC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652743
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.
Guo M; Shi JH; Wang PL; Shi DZ
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
